Crossref journal-article
Wiley
Immunological Reviews (311)
Abstract

Summary: In the last few years, the routine development of knockout and transgenic mice and the ease with which rare progenitor populations can be isolated from hematopoietic organs and cultured in vitro has facilitated significant advances in understanding the lineage and development of natural killer (NK) cells. Fluorescence‐activated cell sorter analyses have identified a common lymphoid progenitor capable of giving rise to NK, T, and B cells, confirming the lymphoid origin of NK cells. Knockout and transgenic mouse models have pointed to an absolutely critical role for signals sent through the interleukin (IL)‐2/lS receptor β (CD 122) chain and common γ (γc) chain for NK development. Such signals are likely relayed inside the cell by the tyrosine kinase Jak3, which associates with γc. Recently developed IL‐15 and IL‐15 receptor a knockout mice have pinpointed IL‐15 as the mediator of this signal. Other mouse models have indicated an unexpected role for flt3 ligand in early NK‐cell development as well as minor roles for stem cell factor and IL‐7 in expanding NK‐cell progenitor numbers. Finally, in vitro culture systems have proven useful in identifying the point in NK development at which each of these signals is critical.

Bibliography

Williams, N. S., Klem, J., Puzanov, I. J., Sivakumar, P. V., Schatzle, J. D., Bennett, M., & Kumar, V. (1998). Natural killer cell differentiation: insights from knockout and transgenic mouse models and in vitro systems. Immunological Reviews, 165(1), 47–61. Portico.

Authors 7
  1. Noelle Sevilir Williams (first)
  2. Jennifer Klem (additional)
  3. Igor J. Puzanov (additional)
  4. P. V. Sivakumar (additional)
  5. John D. Schatzle (additional)
  6. Michael Bennett (additional)
  7. Vinay Kumar (additional)
References 131 Referenced 105
  1. 10.1146/annurev.iy.02.040184.002043
  2. 10.1084/jem.186.9.1609
  3. 10.1126/science.1439790
  4. 10.1016/S1074-7613(00)80269-1
  5. 10.1016/S1074-7613(00)80370-2
  6. 10.1016/0092-8674(94)90407-3
  7. 10.1146/annurev.immunol.15.1.155
  8. 10.1073/pnas.91.20.9402
  9. 10.1073/pnas.92.16.7545
  10. 10.1016/S0092-8674(00)80453-5
  11. 10.1016/1074-7613(95)90175-2
  12. 10.1016/0092-8674(90)90301-T
  13. 10.1016/0092-8674(90)90303-V
  14. 10.1016/0092-8674(90)90297-R
  15. 10.1016/0092-8674(93)90325-K
  16. 10.1038/368643a0
  17. 10.1182/blood.V91.4.1101
  18. 10.1084/jem.178.3.1079
  19. 10.1002/eji.1830270203
  20. 10.1073/pnas.91.16.7553
  21. 10.1182/blood.V83.9.2594.2594 / Blood / Differentiation of natural killer (NK) cells from human primitive marrow progenitors in stroma‐based long‐term culture system: identification of a CD34+7+ NK progenitor by Miller JS (1994)
  22. 10.1182/blood.V85.12.3538.bloodjournal85123538 / Blood / Lymphokine requirement for (he generation of natural killer cells from CD34+ hematopoietic progenitor cells by Shibuya A (1995)
  23. 10.1084/jem.184.5.1845
  24. 10.1182/blood.V87.7.2632.bloodjournal8772632
  25. 10.1182/blood.V88.10.3901.bloodjournal88103901 / Blood / Role of lL‐2. IL‐7, and IL‐15 in natural killer differentation from cord blood hematopoietic progenitor cells and from γc transduced severe combined immunodeficiency XI bone marrow cells by Cavazzana‐Calvo M (1996)
  26. 10.1002/j.1460-2075.1990.tb08305.x
  27. {'key': 'e_1_2_1_28_2', 'first-page': '691', 'article-title': "Natural killing by spleen cells from W/W' and Sl/Sld anemic mice", 'volume': '9', 'author': 'Seaman WE', 'year': '1981', 'journal-title': 'Exp Hematol'} / Exp Hematol / Natural killing by spleen cells from W/W' and Sl/Sld anemic mice by Seaman WE (1981)
  28. 10.4049/jimmunol.134.6.3731 / J Immunol / Origin and differentiation of natural killer cells. I, characteristics of a transplantable NK cell precursor by Hackett J (1985)
  29. 10.1016/0092-8674(91)90326-T
  30. {'key': 'e_1_2_1_31_2', 'first-page': '1368', 'article-title': 'Expression of flt3 receptor and flt3–ligand in human leukemia‐lymphoma cell lines', 'volume': '9', 'author': 'Meierhoff G', 'year': '1995', 'journal-title': 'Leukemia'} / Leukemia / Expression of flt3 receptor and flt3–ligand in human leukemia‐lymphoma cell lines by Meierhoff G (1995)
  31. {'key': 'e_1_2_1_32_2', 'first-page': '105b', 'article-title': 'The flt3 ligand enhances expansion but not differentiation of human natural killer (NK) cells from CD34+ hematopoetic progenitor cells (HPCs) when combined with interleukin 15 (IL‐IS)', 'volume': '88', 'author': 'Yu H', 'year': '1996', 'journal-title': 'Blood'} / Blood / The flt3 ligand enhances expansion but not differentiation of human natural killer (NK) cells from CD34+ hematopoetic progenitor cells (HPCs) when combined with interleukin 15 (IL‐IS) by Yu H (1996)
  32. {'key': 'e_1_2_1_33_2', 'first-page': '474a', 'article-title': 'Targeted disruption of the flt3 ligand gene in mice affects multiple hematopoietic lineages, including natural killer cells, B lymphocytes, and dendritic cells', 'volume': '88', 'author': 'McKenna HJ', 'year': '1996', 'journal-title': 'Blood'} / Blood / Targeted disruption of the flt3 ligand gene in mice affects multiple hematopoietic lineages, including natural killer cells, B lymphocytes, and dendritic cells by McKenna HJ (1996)
  33. 10.1016/1074-7613(95)90167-1
  34. {'key': 'e_1_2_1_35_2', 'first-page': '3511', 'article-title': 'Antitumor activity and immunotherapeutic properties of flt3–ligand in a murine breast cancer model', 'volume': '57', 'author': 'Chen K', 'year': '1997', 'journal-title': 'Cancer Res'} / Cancer Res / Antitumor activity and immunotherapeutic properties of flt3–ligand in a murine breast cancer model by Chen K (1997)
  35. 10.1038/nm0697-625
  36. 10.4049/jimmunol.142.11.3875 / J Immunol / Normal B cell precursors responsive to recombinant murine IL‐7 and inhibition of IL–7 activity by transforming growth facLor‐β by Lee G (1989)
  37. 10.1093/intimm/1.5.526
  38. 10.1084/jem.181.4.1519
  39. 10.4049/jimmunol.157.6.2366 / J Immunol / Inhibition of γδ T cell development and early thymocyte maturation in IL‐7‐/‐ mice by Moore TA (1996)
  40. 10.1084/jem.180.5.1955
  41. 10.1084/jem.184.1.289
  42. 10.1084/jem.171.1.173
  43. 10.1084/jem.170.4.1103
  44. 10.1182/blood.V84.3.841.841
  45. 10.4049/jimmunol.150.12.5263 / J Immunol / Genesis of human oncolydc natural killer cells from primitive CD34+ CD33‐ bone marrow progenitors by Lotzova E (1993)
  46. 10.1126/science.8235625
  47. 10.1073/pnas.92.2.377
  48. 10.1016/1074-7613(95)90047-0
  49. 10.1016/0092-8674(93)90167-O
  50. 10.1016/1074-7613(95)90066-7
  51. 10.1126/science.270.5237.800
  52. 10.1126/science.270.5237.794
  53. 10.1146/annurev.med.47.1.229
  54. 10.1002/jlb.57.5.763
  55. 10.1126/science.8178155
  56. 10.1002/j.1460-2075.1994.tb06576.x / EMBOJ / Utilization of the β and γ chains of the IL‐2 receptor by the novel cytokine IL‐15 by Giri JG (1994)
  57. 10.1002/j.1460-2075.1995.tb00035.x
  58. 10.1084/jem.184.2.325
  59. 10.4049/jimmunol.157.10.4282 / J Immunol / IL‐15 can substitute for the marrow microenvironment in the differentiation of natural killer cells by Puzanov IJ (1996)
  60. 10.1084/jem.185.3.499
  61. 10.1084/jem.180.2.673
  62. 10.1084/jem.184.5.2043
  63. 10.1016/S1074-7613(00)80443-4
  64. 10.1038/35636
  65. 10.4049/jimmunol.155.3.1020 / J Immunol / Natural T cells: cells that co‐express NKRP‐1 and TCR by Bix M (1995)
  66. 10.4049/jimmunol.147.7.2222 / J Immunol / A novel monoclonal antibody agains murine IL‐2 receptor p‐chain. Characterization of receptor expression in normal lymphoid cells and El‐4 cells by Tanaka T (1991)
  67. 10.1016/0167-5699(96)80582-2
  68. 10.1073/pnas.89.14.6506
  69. 10.1084/jem.180.3.1097
  70. 10.1084/jem.179.4.1285
  71. 10.1126/science.7907820
  72. 10.1126/science.7538697
  73. 10.1084/jem.186.2.331
  74. 10.1084/jem.180.2.653
  75. 10.1084/jem.185.8.1395
  76. 10.4049/jimmunol.159.12.5931 / J Immunol / Role for IL‐15/IL‐15 receptor β‐chain in natural killer 1.1 + T cell receptor‐αβ+ cell development by Ohteki T (1997)
  77. 10.4049/jimmunol.120.6.1849 / J Immunol / Spontaneous cell‐mediated cytotoxicity in humans: role of interferon and immunoglobulins by Trinchieri G (1978)
  78. 10.1002/ijc.2910200309
  79. 10.1016/0167-5699(90)90097-S
  80. 10.1126/science.7716543
  81. 10.1016/1074-7613(95)90025-X
  82. 10.4049/jimmunol.155.5.2306 / J Immunol / Molecular cloning of NKB1: a natural killer cell receptor for HLA‐B allotypes by D'Andrea A (1995)
  83. 10.4049/jimmunol.142.5.1727 / J Immunol / Molecular cloning and characterization of a novel murine T cell surface antigen, YE1/48 by Chan P‐Y (1989)
  84. 10.4049/jimmunol.153.3.1068 / J Immunol / Ly‐49 multigene family expressed by IL‐2–activated NK cells by Smith HR (1994)
  85. 10.1111/j.1600-065X.1997.tb00952.x
  86. 10.1111/j.1600-065X.1997.tb00941.x
  87. 10.1084/jem.185.4.673
  88. 10.1016/S1074-7613(00)80441-0
  89. 10.1084/jem.156.4.1222
  90. 10.1128/iai.41.3.992-997.1983 / Infect Immun / Interleukin 2 enhances natural killer cell activity through induction of γ interferon by Weigent DA (1983)
  91. 10.1146/annurev.iy.13.040195.001343
  92. 10.1038/378088a0
  93. 10.4049/jimmunol.156.11.4274 / J Immunol / Cloning of the cDNA for human IFN‐γ inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein by Ushio S (1996)
  94. 10.1126/science.8456300
  95. 10.1016/S1074-7613(00)80413-6 / Immunity / IL‐12–deficient mice are defective in IFNγ production and type 1 cytokine responses by Magram J (1996)
  96. 10.1016/S1074-7613(00)80543-9
  97. 10.1073/pnas.92.16.7307
  98. 10.1084/jem.181.5.1755
  99. 10.1038/382174a0
  100. 10.1038/382171a0
  101. 10.1084/jem.170.1.73
  102. 10.1146/annurev.iy.09.040191.002325
  103. 10.1016/0092-8674(92)90125-V
  104. 10.1016/0092-8674(94)90115-5
  105. 10.1084/jem.186.12.1957
  106. 10.1084/jem.184.5.1725
  107. 10.1016/0008-8749(89)90190-1
  108. {'key': 'e_1_2_1_109_2', 'first-page': '2006', 'article-title': 'Hugo P Thymic shared antigen‐1. A novel thymocyte marker discriminating immature from mature thymocyte subsets', 'volume': '148', 'author': 'Godfrey Dl', 'year': '1992', 'journal-title': 'J Imnumol'} / J Imnumol / Hugo P Thymic shared antigen‐1. A novel thymocyte marker discriminating immature from mature thymocyte subsets by Godfrey Dl (1992)
  109. 10.1182/blood.V84.1.111.111 / Blood / Thymic stem cells in mouse bone marrcjw by Antica M (1994)
  110. 10.1182/blood.V86.5.1850.bloodjournal8651850 / Blood / T‐cell lineage commitment and cytokine responses of thymic progenitors by Moore TA (1995)
  111. {'key': 'e_1_2_1_112_2', 'first-page': '1012', 'article-title': 'Flt3–ligand production by human bone marrow stromal cells', 'volume': '10', 'author': 'Lisovsky M', 'year': '1996', 'journal-title': 'Leukemia'} / Leukemia / Flt3–ligand production by human bone marrow stromal cells by Lisovsky M (1996)
  112. 10.1084/jem.181.4.1357
  113. 10.1182/blood.V90.10.3903 / Blood / Flt 3 ligand enhances the yield of primitive cells after ex vivo cultivation of CD3 4+ CD3 8dim cells and CD34+ CD38dm CD33dim HLA‐DR+ cells by Dooley DC (1997)
  114. {'key': 'e_1_2_1_115_2', 'volume-title': 'NK cells and cancer: biology and therapy', 'author': 'Williams NS'} / NK cells and cancer: biology and therapy by Williams NS
  115. 10.4049/jimmunol.151.1.60 / J Immunol / A novel function‐associated molecule related to non‐MHC‐restricted cytotoxicity mediated by activated natural killer cells and T cells by Garni‐Wagner BA (1993)
  116. 10.1038/358066a0
  117. 10.1111/j.1600-065X.1997.tb00940.x
  118. 10.1111/j.1600-065X.1997.tb00936.x
  119. 10.1111/j.1600-065X.1997.tb00938.x
  120. 10.1002/eji.1830271204
  121. 10.1002/eji.1830250904
  122. 10.1084/jem.173.4.1017
  123. 10.4049/jimmunol.157.11.4741
  124. 10.1084/jem.185.4.795
  125. 10.1002/eji.1830270230
  126. 10.4049/jimmunol.157.7.2804 / J Immunol / Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses by Brumbaugh KM (1996)
  127. 10.1111/j.1600-065X.1997.tb00949.x
  128. 10.1016/S1074-7613(00)80492-6
  129. 10.1002/eji.1830261032
  130. 10.1038/35869
  131. 10.1084/jem.187.5.813
Dates
Type When
Created 19 years, 4 months ago (April 30, 2006, 12:56 a.m.)
Deposited 1 year, 10 months ago (Oct. 28, 2023, 2:56 a.m.)
Indexed 1 week, 6 days ago (Aug. 23, 2025, 1:02 a.m.)
Issued 26 years, 11 months ago (Oct. 1, 1998)
Published 26 years, 11 months ago (Oct. 1, 1998)
Published Online 19 years, 4 months ago (April 28, 2006)
Published Print 26 years, 11 months ago (Oct. 1, 1998)
Funders 0

None

@article{Williams_1998, title={Natural killer cell differentiation: insights from knockout and transgenic mouse models and in vitro systems}, volume={165}, ISSN={1600-065X}, url={http://dx.doi.org/10.1111/j.1600-065x.1998.tb01229.x}, DOI={10.1111/j.1600-065x.1998.tb01229.x}, number={1}, journal={Immunological Reviews}, publisher={Wiley}, author={Williams, Noelle Sevilir and Klem, Jennifer and Puzanov, Igor J. and Sivakumar, P. V. and Schatzle, John D. and Bennett, Michael and Kumar, Vinay}, year={1998}, month=oct, pages={47–61} }